Movatterモバイル変換

[0]ホーム
URL:

Jump to content
WikipediaThe Free Encyclopedia
Search

AM-694

From Wikipedia, the free encyclopedia
Chemical compound

Pharmaceutical compound
AM-694
Legal status
Legal status
Identifiers
  • 1-[(5-Fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone
CAS Number
PubChemCID
ChemSpider
UNII
ChEBI
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC20H19FINO
Molar mass435.281 g·mol−1
3D model (JSmol)
  • Ic2ccccc2C(=O)c1cn(CCCCCF)c3ccccc13
  • InChI=1S/C20H19FINO/c21-12-6-1-7-13-23-14-17(15-8-3-5-11-19(15)23)20(24)16-9-2-4-10-18(16)22/h2-5,8-11,14H,1,6-7,12-13H2 checkY
  • Key:LFFIIZFINPPEMC-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

AM-694 (1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole) is adesigner drug that acts as a potent and selectiveagonist for thecannabinoid receptorCB1. It is used in scientific research for mapping the distribution of CB1 receptors.[1]

Pharmacology

[edit]

AM-694 is anagonist forcannabinoid receptors. It has aKi of 0.08 nM atCB1 and 18 times selectivity overCB2 with aKi of 1.44 nM.[2] It is unclear what is responsible for this unusually high CB1 binding affinity, but it makes the18Fradiolabelled derivative of AM-694 useful for mapping the distribution of CB1 receptors in the body.[1]

Metabolism

[edit]

Pathways ofmetabolism includehydrolytic defluorination,carboxylation, andmonohydroxylation of theN-alkyl chain.[3][4]

See also

[edit]

References

[edit]
  1. ^abWillis PG, Katoch-Rouse R, Horti AG (August 2003). "Regioselective F-18 radiolabeling of AM694, a CB1 cannabinoid receptor ligand".Journal of Labelled Compounds and Radiopharmaceuticals.46 (9):799–804.doi:10.1002/jlcr.720.
  2. ^WO patent 200128557,Makriyannis A, Deng H, "Cannabimimetic indole derivatives", granted 2001-06-07 
  3. ^Grigoryev A, Kavanagh P, Melnik A (February 2013). "The detection of the urinary metabolites of 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone (AM-694), a high affinity cannabimimetic, by gas chromatography - mass spectrometry".Drug Testing and Analysis.5 (2):110–5.doi:10.1002/dta.1336.PMID 22522907.
  4. ^Apirakkan O, Gavrilović I, Cowan DA, Abbate V (July 2020). "In Vitro Phase I Metabolic Profiling of the Synthetic Cannabinoids AM-694, 5F-NNEI, FUB-APINACA, MFUBINAC, and AMB-FUBINACA".Chemical Research in Toxicology.33 (7):1653–1664.doi:10.1021/acs.chemrestox.9b00466.PMID 32301604.S2CID 215803607.
Phytocannabinoids
(comparison)
Cannabibutols
Cannabichromenes
Cannabicyclols
Cannabidiols
Cannabielsoins
Cannabigerols
Cannabiphorols
Cannabinols
Cannabitriols
Cannabivarins
Delta-8-tetrahydrocannabinols
Delta-9-tetrahydrocannabinols
Delta-10-Tetrahydrocannabinols
Miscellaneous cannabinoids
Active metabolites
Endocannabinoids
Synthetic
cannabinoid
receptor
agonists /
neocannabinoids
Classical cannabinoids
(dibenzopyrans)
Non-classical
cannabinoids
Adamantoylindoles
Benzimidazoles
Benzoylindoles
Cyclohexylphenols
Eicosanoids
Indazole-3-
carboxamides
Indole-3-carboxamides
Indole-3-carboxylates
Naphthoylindazoles
Naphthoylindoles
Naphthoylpyrroles
Naphthylmethylindenes
Naphthylmethylindoles
Phenylacetylindoles
Pyrazolecarboxamides
Tetramethylcyclo-
propanoylindazoles
Tetramethylcyclo-
propanoylindoles
Others
AllostericCBRTooltip Cannabinoid receptorligands
Endocannabinoid
enhancers
(inactivation inhibitors)
Anticannabinoids
(antagonists/inverse
agonists/antibodies)
Retrieved from "https://en.wikipedia.org/w/index.php?title=AM-694&oldid=1268800433"
Categories:
Hidden categories:
[8]ページ先頭
©2009-2025 Movatter.jp